Yasuhiro Ogawa Selected Research

Sandhoff Disease (Sandhoff's Disease)

1/2021	[Glial cells and pharmacological targets in Sandhoff disease].
6/2020	Abnormal organization during neurodevelopment in a mouse model of Sandhoff disease.
10/2018	Inhibition of astrocytic adenosine receptor A2A attenuates microglial activation in a mouse model of Sandhoff disease.
1/2018	Improvement in dysmyelination by the inhibition of microglial activation in a mouse model of Sandhoff disease.
1/2017	FcRγ-dependent immune activation initiates astrogliosis during the asymptomatic phase of Sandhoff disease model mice.
1/2017	Abnormal differentiation of Sandhoff disease model mouse-derived multipotent stem cells toward a neural lineage.
1/2013	Impaired neural differentiation of induced pluripotent stem cells generated from a mouse model of Sandhoff disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhiro Ogawa Research Topics

Disease

40	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2002
26	Neoplasms (Cancer) 06/2017 - 05/2002
16	Carcinoma (Carcinomatosis) 06/2017 - 06/2008
10	Osteosarcoma (Osteogenic Sarcoma) 02/2016 - 10/2003
8	Neoplasm Metastasis (Metastasis) 11/2015 - 11/2003
7	Sandhoff Disease (Sandhoff's Disease) 01/2021 - 01/2013
5	Pain (Aches) 01/2022 - 11/2010
5	Lymphatic Metastasis 06/2017 - 04/2006
5	Non-alcoholic Fatty Liver Disease 03/2012 - 05/2002
4	Inflammation (Inflammations) 06/2022 - 01/2018
4	Myocardial Infarction 08/2020 - 11/2006
4	Alcoholic Fatty Liver 02/2010 - 01/2003
4	Fatty Liver 02/2010 - 08/2002
3	Dementia (Dementias) 01/2022 - 05/2020
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2021 - 01/2018
3	Hepatocellular Carcinoma (Hepatoma) 05/2012 - 01/2008
3	Cicatrix (Scar) 12/2011 - 09/2010
3	Melanoma (Melanoma, Malignant) 09/2011 - 05/2004
3	Atherosclerosis 05/2007 - 03/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2007 - 10/2004
2	Sepsis (Septicemia) 06/2022 - 01/2021
2	Poisoning 04/2021 - 06/2003
2	Narcolepsy 01/2017 - 10/2015
2	Gliosis 01/2017 - 01/2017
2	Cataplexy 01/2017 - 10/2015
2	von Hippel-Lindau Disease (von Hippel Lindau Disease) 09/2014 - 08/2006
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2014 - 08/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2014 - 09/2008
2	Sarcoma (Soft Tissue Sarcoma) 09/2011 - 11/2010
2	Rupture 10/2009 - 08/2004
2	Insulin Resistance 08/2007 - 03/2003
2	Type 2 Diabetes Mellitus (MODY) 05/2007 - 09/2003
2	Coronary Disease (Coronary Heart Disease) 09/2006 - 03/2003
2	Residual Neoplasm 09/2003 - 05/2002
1	Ataxia (Dyssynergia) 10/2022
1	Anemia 10/2022
1	Alcoholism (Alcohol Abuse) 10/2022
1	Skin Diseases (Skin Disease) 01/2022

Drug/Important Bio-Agent (IBA)

22	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 06/2017 - 10/2003
17	EnzymesIBA 06/2017 - 08/2004
8	Hyaluronic Acid (Hyaluronan)IBA 06/2017 - 08/2004
6	Oxygen (Dioxygen)IBA 04/2016 - 06/2008
6	Tamoxifen FDA LinkGeneric 10/2005 - 05/2002
4	OrexinsIBA 06/2022 - 12/2016
4	CatalaseIBA 02/2016 - 03/2009
4	Peroxidase (Myeloperoxidase)IBA 01/2016 - 03/2004
4	Therapeutic UsesIBA 09/2011 - 07/2003
4	oxidized low density lipoproteinIBA 08/2007 - 08/2002
4	LDL Lipoproteins (beta Lipoproteins)IBA 08/2007 - 08/2002
4	Free RadicalsIBA 09/2004 - 10/2003
4	Hydroxyl RadicalIBA 09/2004 - 10/2003
3	Pharmaceutical PreparationsIBA 09/2021 - 02/2016
3	G(M2) Ganglioside (Ganglioside GM2)IBA 01/2018 - 01/2017
3	Hexosaminidases (Hexosaminidase)IBA 01/2017 - 01/2013
3	PeroxidasesIBA 04/2016 - 06/2008
3	Estrogen ReceptorsIBA 11/2015 - 05/2002
3	Insulin (Novolin)FDA Link 02/2010 - 03/2003
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2004 - 05/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2004 - 03/2004
2	LipopolysaccharidesIBA 06/2022 - 12/2016
2	NeuropeptidesIBA 06/2022 - 12/2016
2	Hexosaminidase BIBA 01/2021 - 01/2018
2	GlycosphingolipidsIBA 01/2018 - 01/2013
2	LipidsIBA 12/2017 - 05/2007
2	taxaneIBA 01/2017 - 11/2015
2	Orexin ReceptorsIBA 01/2017 - 10/2015
2	Epirubicin (Ellence)FDA LinkGeneric 01/2017 - 04/2006
2	DNA (Deoxyribonucleic Acid)IBA 02/2016 - 03/2005
2	AntioxidantsIBA 01/2016 - 06/2003
2	Radiation-Sensitizing AgentsIBA 11/2015 - 09/2011
2	Hypoglycemic Agents (Hypoglycemics)IBA 02/2013 - 05/2007
2	Aromatase InhibitorsIBA 09/2011 - 01/2008
2	Choline (Choline Chloride)IBA 02/2010 - 01/2009
2	Cisplatin (Platino)FDA LinkGeneric 01/2010 - 11/2002
2	GadoliniumIBA 01/2009 - 12/2004
2	Proteins (Proteins, Gene)FDA Link 05/2008 - 05/2005
2	Malondialdehyde (Propanedial)IBA 08/2007 - 05/2007
2	Estrogens (Estrogen)FDA Link 10/2005 - 05/2002
2	AnthracyclinesIBA 05/2005 - 11/2002
2	Toremifene (Fareston)FDA Link 02/2004 - 05/2002
2	Contrast MediaIBA 09/2003 - 07/2003
1	ZincIBA 10/2022
1	CopperIBA 10/2022
1	GalactosidasesIBA 09/2021

Therapy/Procedure

25	Radiotherapy 01/2019 - 05/2003
16	Therapeutics 01/2017 - 05/2002
15	Drug Therapy (Chemotherapy) 06/2017 - 01/2002
10	Neoadjuvant Therapy 03/2010 - 07/2003
5	Particle Accelerators 07/2016 - 03/2009
5	Segmental Mastectomy (Lumpectomy) 01/2008 - 05/2002
4	Percutaneous Coronary Intervention 08/2020 - 11/2006
3	Home Nursing (Nursing, Home) 01/2022 - 05/2020
3	Operative Surgical Procedures 01/2022 - 09/2011
2	Activities of Daily Living (ADL) 04/2021 - 05/2020
2	Oral Administration 01/2020 - 03/2005
2	Stents 01/2019 - 12/2017
2	Induction Chemotherapy 01/2017 - 11/2015
2	Radiofrequency Ablation 09/2014 - 02/2013
2	Lymph Node Excision (Lymph Node Dissection) 04/2006 - 01/2006
2	Local Anesthesia 02/2004 - 05/2002